From July 1, 2022 to December 31, 2022, the company has repurchased 2,335,000 shares, representing 0.41% for HKD 8 million. With this, the company has completed the repurchase of 3,132,000 shares, representing 0.55% for HKD 10.9 million under the buyback announced on May 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.24 HKD | +2.28% | -3.03% | -10.04% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.04% | 159M | |
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-14.82% | 15.36B | |
-8.82% | 11.95B | |
-16.29% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- 1061 Stock
- News Essex Bio-Technology Limited
- Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.